Observational cohort analysis shows GLP-1 RA use links to nonarteritic anterior ischemic optic neuropathy risk in older patients with diabetes, suggesting careful assessment needed.
This observational cohort study assesses the effects of glucagon-like peptide-1 receptor agonist (GLP-1 RA) use on the incidence of nonarteritic anterior ischemic optic neuropathy in older patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Fung et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: